1998
DOI: 10.1093/ajcp/110.2.178
|View full text |Cite
|
Sign up to set email alerts
|

IgG Platelet Antibodies in EDTA-Dependent Pseudothrombocytopenia Bind to Platelet Membrane Glycoprotein IIb

Abstract: A b s t r a c t EDTA-dependent pseudothrombocytopenia (PTCP) consists of an inappropriate low platelet count caused by autoantibodies present in the serumIn EDTA-dependent pseudothrombocytopenia (PTCP), autoantibodies present in serum samples react with platelets in blood anticoagulated with EDTA causing platelet agglutination and an incorrect low platelet count. The minimal EDTA concentration (0.3-mmol/L of Na,-EDTA) required to produce platelet agglutination is much lower than that needed to prevent clotting… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
38
0
4

Year Published

2005
2005
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(42 citation statements)
references
References 7 publications
0
38
0
4
Order By: Relevance
“…Platelet clumping in blood samples collected in EDTA occurs due to the chelating effect of EDTA, which alters the GPIIb-IIIa molecule on the platelet surface, thereby leading to binding of a naturally occurring IgG antibody to GPIIb [12]. Other anticoagulants, such as sodium citrate or heparin, do not affect GPIIb-IIIa, and therefore do not lead to platelet agglutination in these cases [13].…”
Section: Discussionmentioning
confidence: 99%
“…Platelet clumping in blood samples collected in EDTA occurs due to the chelating effect of EDTA, which alters the GPIIb-IIIa molecule on the platelet surface, thereby leading to binding of a naturally occurring IgG antibody to GPIIb [12]. Other anticoagulants, such as sodium citrate or heparin, do not affect GPIIb-IIIa, and therefore do not lead to platelet agglutination in these cases [13].…”
Section: Discussionmentioning
confidence: 99%
“…Psödotrombositopeniyi saptamak için farklı yöntem-ler bulunmuştur. EDTA yerine diğer antikoagülanların (sodyum sitrat, oksalat ve heparin) kullanılması [12,13], EDTA ile antikoagüle edilmiş kanın 37 0 C'ye getirilerek incelenmesi [1,4], mikroskop altında trombosit kü-meleşmesinin saptanması [5], mekanizması henüz bilinmemesine rağmen kanamisin eklenmiş kan örnekleri-nin kullanılması bu yöntemlerdendir [8]. Çalışmamızda psödotrombositopeniyi saptamak amacıyla EDTA yerine antikoagülan olarak ilk aşamada sitratı seçtik.…”
Section: Discussionunclassified
“…Eğer sitratlı örnekte gerçek trombosit sayısına ulaşılamazsa heparin veya diğer antikoagülanlar düşünülebilir. Kan örneğinin 37 0 C'ye getirilerek incelenmesinde temel mekanizma, glikoprotein IIb/IIIa kompleksinin bu sıcaklıkta ayrışmasıyla trombositlerin kümeleşememe-sine bağlanmıştır [4]. Ancak psödotrombositopeniye sahip bazı vakalarda bilinmeyen bir mekanizma nedeniyle kümeleşmenin 37 °C'de de devam ettiği bildirilmiştir [1].…”
Section: Discussionunclassified
See 1 more Smart Citation
“…Variations in PC appear to be only partly due to the intrinsic variability of the test, because, at t 90 , (i) the percentage of patients exhibiting a decrease in PC was significantly higher than that of patients exhibiting an increase of PC, both in EDTA-and CPT-samples; (ii) the prevalence of platelet agglutinates was highest in blood smears of patients exhibiting a decrease in PC; (iii) the percentage of patients shifting from a lower to a higher bleeding risk category was higher than that of patients shifting from a higher to a lower risk category. The mechanisms responsible for the observed artifact are likely the same as those responsible for pseudothrombocytopenia [18], because the use of CPT instead of EDTA attenuated the severity of this artifact, albeit it did not completely prevent it [19].…”
Section: American Journal Of Hematologymentioning
confidence: 99%